The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.”
Tag Archive | "Aduhelm"
Aduhelm: Alzheimer’s Drug Approval ‘Rife With Irregularities’
Posted on 03 January 2023.
Posted in HealthComments (0)
Forget Any Changes To Medicare Part B Premium Rates
Posted on 11 May 2022.
About three months ago, I reported that people on Medicare were being over-charged for their Part B (doctor’s care) premium rates because of the inflated cost of a new drug to treat Alzheimer’s disease.
Posted in Pushback, Your MoneyComments (0)
Medicare Weighs Cut In Premiums After Limiting Alzheimer’s Drug
Posted on 09 April 2022.
Medicare said Thursday it’s considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs.
Posted in Health, Your MoneyComments (0)
Patients Divided Over Aduhelm: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill‘?
Posted on 08 March 2022.
If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might think everyone living with Alzheimer’s wants unfettered access to Aduhelm, a controversial new treatment.
Posted in HealthComments (0)
Inside The Tactical Tug Of War Over The Controversial Alzheimer’s Drug Aduhelm
Posted on 18 February 2022.
The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug.
Posted in HealthComments (0)
Medicare Proposal Would Cover Aduhelm If Beneficiaries Enrolled In Clinical Trials
Posted on 17 January 2022.
On Nov. 12, the Center for Medicare and Medicaid Services (CMS) announced the Medicare Part B (doctor’s care) premium rates for 2022 would rise from $148.50 per month in 2021, to $170.10 in 2022.
Posted in PushbackComments (0)